233 related articles for article (PubMed ID: 24871964)
21. Clinical factors affecting spot urine fractionated metanephrines in patients suspected pheochromocytoma/paraganglioma.
Bokuda K; Yatabe M; Seki Y; Ichihara A
Hypertens Res; 2020 Jun; 43(6):543-549. PubMed ID: 32020083
[TBL] [Abstract][Full Text] [Related]
22. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors.
de Jong WH; Eisenhofer G; Post WJ; Muskiet FA; de Vries EG; Kema IP
J Clin Endocrinol Metab; 2009 Aug; 94(8):2841-9. PubMed ID: 19567530
[TBL] [Abstract][Full Text] [Related]
23. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of various biochemical parameters for the diagnosis of pheochromocytoma in patients with adrenal mass.
Unger N; Pitt C; Schmidt IL; Walz MK; Schmid KW; Philipp T; Mann K; Petersenn S
Eur J Endocrinol; 2006 Mar; 154(3):409-17. PubMed ID: 16498054
[TBL] [Abstract][Full Text] [Related]
25. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases.
Gerlo EA; Sevens C
Clin Chem; 1994 Feb; 40(2):250-6. PubMed ID: 7906208
[TBL] [Abstract][Full Text] [Related]
26. Choice of biochemical test for diagnosis of pheochromocytoma: validation of plasma metanephrines.
Eisenhofer G; Lenders JW; Pacak K
Curr Hypertens Rep; 2002 Jun; 4(3):250-5. PubMed ID: 12003709
[TBL] [Abstract][Full Text] [Related]
27. [Biological diagnosis of pheochromocytoma: is there an interest in urinary metanephrines measurement over 3 consecutive days?].
Bettacchioli É; Leven C; Thuillier P; Plée-Gautier E; Lapègue M; Carré JL; Padelli M
Ann Biol Clin (Paris); 2018 Oct; 76(5):537-544. PubMed ID: 30174318
[TBL] [Abstract][Full Text] [Related]
28. The role of urinary fractionated metanephrines in the diagnosis of phaeochromocytoma.
Jeyaraman K; Natarajan V; Thomas N; Jacob PM; Nair A; Shanthly N; Oommen R; Varghese G; Joseph FJ; Seshadri MS; Rajaratnam S
Indian J Med Res; 2013 Feb; 137(2):316-23. PubMed ID: 23563375
[TBL] [Abstract][Full Text] [Related]
29. Comparison of plasma free metanephrines between healthy dogs and 3 dogs with pheochromocytoma.
Green BA; Frank EL
Vet Clin Pathol; 2013 Dec; 42(4):499-503. PubMed ID: 24320781
[TBL] [Abstract][Full Text] [Related]
30. [Biological diagnosis of pheochromocytoma: impact of technological improvement].
Peyrin L; Mornex R
Ann Biol Clin (Paris); 1993; 51(10-11):835-65. PubMed ID: 8210060
[TBL] [Abstract][Full Text] [Related]
31. Plasma chromogranin A or urine fractionated metanephrines follow-up testing improves the diagnostic accuracy of plasma fractionated metanephrines for pheochromocytoma.
Algeciras-Schimnich A; Preissner CM; Young WF; Singh RJ; Grebe SK
J Clin Endocrinol Metab; 2008 Jan; 93(1):91-5. PubMed ID: 17940110
[TBL] [Abstract][Full Text] [Related]
32. The value of immunoassays for metanephrines in the biochemical diagnosis of pheochromocytomas.
Unger N; Deutschbein T; Walz MK; Mann K; Petersenn S
Horm Metab Res; 2009 Sep; 41(9):676-9. PubMed ID: 19557670
[TBL] [Abstract][Full Text] [Related]
33. Free plasma metanephrines as a screening test for pheochromocytoma in low-risk patients.
Václavík J; Stejskal D; Lacnák B; Lazárová M; Jedelský L; Kadalová L; Janosová M; Frysák Z; Vlcek P
J Hypertens; 2007 Jul; 25(7):1427-31. PubMed ID: 17563565
[TBL] [Abstract][Full Text] [Related]
34. Biochemical diagnosis of pheochromocytoma: which test is best?
Lenders JW; Pacak K; Walther MM; Linehan WM; Mannelli M; Friberg P; Keiser HR; Goldstein DS; Eisenhofer G
JAMA; 2002 Mar; 287(11):1427-34. PubMed ID: 11903030
[TBL] [Abstract][Full Text] [Related]
35. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
[TBL] [Abstract][Full Text] [Related]
36. Clues to the diagnosis of pheochromocytoma from the differential tissue metabolism of catecholamines.
Eisenhofer G; Lenders JW
Adv Pharmacol; 1998; 42():374-7. PubMed ID: 9327920
[No Abstract] [Full Text] [Related]
37. Performance of plasma fractionated free metanephrines by enzyme immunoassay in the diagnosis of pheochromocytoma and paraganglioma.
Sarathi V; Pandit R; Jagtap V; Lila AR; Bandgar TR; Menon PS; Varthakavi P; Raghavan VP; Shah NS
Endocr Pract; 2011; 17(5):759-65. PubMed ID: 21742610
[TBL] [Abstract][Full Text] [Related]
38. Symptom-dependent cut-offs of urine metanephrines improve diagnostic accuracy for detecting pheochromocytomas in two separate cohorts, compared to symptom-independent cut-offs.
Cho YY; Song KH; Kim YN; Ahn SH; Kim H; Park S; Suh S; Kim BJ; Lee SY; Chun S; Koh JM; Lee SH; Kim JH
Endocrine; 2016 Oct; 54(1):206-216. PubMed ID: 27481364
[TBL] [Abstract][Full Text] [Related]
39. Case report of a phantom pheochromocytoma.
Joyce CM; Melvin A; O'Shea PM; Costelloe SJ; O'Halloran DJ
Biochem Med (Zagreb); 2020 Jun; 30(2):021003. PubMed ID: 32550819
[TBL] [Abstract][Full Text] [Related]
40. Circulating and urinary catecholamines in pheochromocytoma. Diagnostic and pathophysiologic implications.
Bravo EL; Tarazi RC; Gifford RW; Stewart BH
N Engl J Med; 1979 Sep; 301(13):682-6. PubMed ID: 481462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]